Everence Capital Management Inc Jazz Pharmaceuticals PLC Transaction History
Everence Capital Management Inc
- $1.47 Billion
- Q1 2025
A detailed history of Everence Capital Management Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Everence Capital Management Inc holds 2,250 shares of JAZZ stock, worth $254,002. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,250
Previous 2,250
-0.0%
Holding current value
$254,002
Previous $277,000
0.72%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
554Shares Held
59.8MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$694 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$681 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$286 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$250 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$230 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.08B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...